MICHAEL W BONNEY Insider Trading
Get free email notifications about insider trading for MICHAEL W BONNEY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL W BONNEY. MICHAEL W BONNEY is a Director in BRISTOL MYERS SQUIBB CO ($BMY) and a in CELGENE CORP /DE/ ($CELG) and a Director in CELGENE CORP /DE/ ($CELG) and a Director in NPS PHARMACEUTICALS INC ($NPSP) and an Chief Executive Officer in CUBIST PHARMACEUTICALS INC ($CBST) and a President & CEO in CUBIST PHARMACEUTICALS INC ($CBST) and a President and CEO in CUBIST PHARMACEUTICALS INC ($CBST) and a Director in Sarepta Therapeutics, Inc. ($SRPT) and a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in Syros Pharmaceuticals, Inc. ($SYRS) and a Director in Global Blood Therapeutics, Inc. ($GBT) and a Director in Tekla World Healthcare Fund ($THW) and a Director in Magenta Therapeutics, Inc. ($MGTA) and a Director in Kaleido Biosciences, Inc. ($KLDO) and an Executive Chair in Kaleido Biosciences, Inc. ($KLDO).
Address: 65 HAYDEN AVENUE LEXINGTON 02421 MA
Companies in which MICHAEL W BONNEY is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 4,000 shares
Current Value: $161,840
Latest Transaction: Jul 06 2020
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BRISTOL MYERS SQUIBB CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 12,501 shares
Current Value: $645,802
Latest Transaction: Jun 14 2021
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CELGENE CORP /DE/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 22 2019
$CELG Market Capitalization: $89.29B
$CELG Previous Close: $116.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CUBIST PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Chief Executive Officer, President & CEO, President and CEO
Holdings: 0 shares
Latest Transaction: Jan 21 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Global Blood Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 10 2016
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kaleido Biosciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL W BONNEY: Director, Executive Chair
Holdings: 1,005,968 shares
Latest Transaction: Jul 01 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Magenta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 215,346 shares
Latest Transaction: Jun 09 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NPS PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL W BONNEY: Director
Holdings: 0 shares
Latest Transaction: Feb 24 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sarepta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 9,126 shares
Current Value: $266,205
Latest Transaction: Feb 28 2020
$SRPT Market Capitalization: $1.60B
$SRPT Previous Close: $29.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL W BONNEY: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2018
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tekla World Healthcare Fund
Industry:
Position of MICHAEL W BONNEY: Director
Holdings: 10,917 shares
Latest Transaction: Aug 18 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL W BONNEY
Sentiment: All, ALNY, BMY, CELG, CBST, GBT, KLDO, MGTA, NPSP, SRPT, SYRS, THW
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | M | 0.00 | 902 | 0 | 0 | |
| Jun 14 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Buy | M | 0.00 | 902 | 0 | 12,501 | 11.6 K to 12.5 K (+7.78 %) |
| Apr 02 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 366 | 0 | 8,930 | |
| Feb 03 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 3,054 | 0 | 8,565 | |
| Jan 05 2021 | BMY | BRISTOL MYERS SQUI ... | BONNEY MICHAEL W | Director | Option Exercise | A | 0.00 | 372 | 0 | 5,468 | |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
| Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 |